key: cord-0858681-gmo6big4
authors: Zhu, Li; Wang, Jian; Huang, Rui; Liu, Longgen; Zhao, Haiyan; Wu, Chao; Zhu, Chuanwu
title: Clinical characteristics of a case series of children with coronavirus disease 2019
date: 2020-04-08
journal: Pediatr Pulmonol
DOI: 10.1002/ppul.24767
sha: 10e39904b941a033c0b05e4b6fda830ddd4d9491
doc_id: 858681
cord_uid: gmo6big4

We reported the clinical characteristics of a case series of 10 patients with coronavirus disease 2019 (COVID‐19) aged from 1 year to 18 years. Seven patients had contact with confirmed COVID‐19 family members before onset. Fever (4 [40.0%]) and cough (3 [30.0%]) were the most common symptoms. No patient showed leucopenia and lymphopenia on admission. Pneumonia was observed in chest CT images in 5 (50.0%) patients. Five (50.0%) patients received antiviral treatment. No patient had severe complications or developed a severe illness in our study. Our study indicated that COVID‐19 children present less severe symptoms and have better outcomes.

In December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection spread rapidly among humans worldwide. 1 The epidemiological, radiological, and clinical characteristics of COVID-10 have been reported in the general population. 2 Elderly patients with comorbidities may be more likely infected by SARS-CoV-2 according to previous reports. 3 In addition, the characteristics of COVID-19 in special populations were also reported. This study was approved by the ethics committees of these hospitals, with a waiver of informed consent.

A total of 10 children with COVID-19 were included in the study (Table 1) No patient showed leucopenia and lymphopenia on admission.

Three of 10 patients (30%) had mildly increased levels of alanine aminotransferase (ALT). The peak level of ALT was 69 U/L.

were normal in all patients. All patients received a chest CT examination on admission. Typical findings of chest CT images were observed in five (50.0%) patients. Of the five patients, two (40.0%) had bilateral and one (20.0%) had unilateral ground-glass opacity.

Oxygen therapy was required in one (10.0%) patients. Five (50.0%) patients received antiviral treatment, including lopinavir/ritonavir (n = 4;

40.0%), interferon α-2b (n = 4; 40.0%), and oseltamivir (n = 1; 10.0%).

One (10.0%) patient was given antibiotic treatment and no patient was treated with corticosteroid or gamma globulin. As of February 25, 2020, The children rarely combine comorbidities and may be less susceptible to developing severe illness than elderly patients. 4 Although the antiviral effect was uncertain, 50.0% of patients received antiviral therapy in this study. However, the benefit of antiviral therapy for COVID-19 remains unclear. In addition, 10.0% of patients received empirical antibacterial therapy, and no patient received corticosteroids or gamma globulin due to the mild illness.

There were several limitations to this study. First, the sample size is small and only 10 childhood patients were enrolled.

The results need to be confirmed by a larger sample study. In addition, as of February 25, 2020, five patients remained in hospital and the clinical outcomes were not available at the time of analysis. Thus, the risk factors of poor prognosis for children patients remains unknown.

In conclusion, compared with adult patients, COVID-19 children present less severe symptoms and have better outcomes. Our results provide valuable information to understanding the epidemiological and clinical features of COVID-19 in children.

This study was supported by the Fundamental Research Funds for the Central Universities (No. 14380459).

Coronavirus infections-more than just the common cold

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Novel coronavirus infection in hospitalized infants under 1 year of age in China

Clinical characteristics of a case series of children with coronavirus disease 2019